{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:08:29Z","timestamp":1791299309323,"version":"4.1.0"},"reference-count":126,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,10]],"date-time":"2016-10-10T00:00:00Z","timestamp":1476057600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["BBA Clinical"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.bbacli.2016.10.001","type":"journal-article","created":{"date-parts":[[2016,10,15]],"date-time":"2016-10-15T16:33:11Z","timestamp":1476549191000},"page":"125-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Controversies and evidence of hepatic resection for hepatocellular carcinoma"],"prefix":"10.1016","volume":"6","author":[{"given":"Jian-Hong","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Torzilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Yang","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le-Qun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bbacli.2016.10.001_bb0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.bbacli.2016.10.001_bb0010","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","author":"European Association For The Study Of The Liver","year":"2012","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.bbacli.2016.10.001_bb0015","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/hep.24199","article-title":"Management of hepatocellular carcinoma: an update","volume":"53","author":"Bruix","year":"2011","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.bbacli.2016.10.001_bb0020","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1872-034X.2010.00673.x","article-title":"Management of hepatocellular carcinoma: report of consensus meeting in the 45th Annual Meeting of the Japan Society of Hepatology (2009)","volume":"40","author":"Arii","year":"2010","journal-title":"Hepatol. Res."},{"issue":"2","key":"10.1016\/j.bbacli.2016.10.001_bb0025","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s12072-010-9165-7","article-title":"Asian Pacific Association for the study of the Liver Consensus recommendations on hepatocellular carcinoma","volume":"4","author":"Omata","year":"2010","journal-title":"Hepatol. Int."},{"issue":"1","key":"10.1016\/j.bbacli.2016.10.001_bb0030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.bbacli.2016.10.001_bb0035","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.bbacli.2016.10.001_bb0040","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1001\/archsurg.143.11.1082","article-title":"Hepatectomy for stage B and stage C hepatocellular carcinoma in the Barcelona Clinic Liver Cancer classification: results of a prospective analysis","volume":"143","author":"Torzilli","year":"2008","journal-title":"Arch. Surg."},{"issue":"7","key":"10.1016\/j.bbacli.2016.10.001_bb0045","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1053\/j.gastro.2008.02.091","article-title":"Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma","volume":"134","author":"Ishizawa","year":"2008","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.bbacli.2016.10.001_bb0050","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1097\/SLA.0b013e31828329b8","article-title":"A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL\/AASLD recommendations?: an observational study of the HCC East-West study group","volume":"257","author":"Torzilli","year":"2013","journal-title":"Ann. Surg."},{"key":"10.1016\/j.bbacli.2016.10.001_bb0055","doi-asserted-by":"crossref","DOI":"10.1002\/jso.24434","article-title":"Association between age and overall survival of patients with hepatocellular carcinoma after hepatic resection","author":"Tan","year":"2016","journal-title":"J. Surg. Oncol."},{"issue":"13","key":"10.1016\/j.bbacli.2016.10.001_bb0060","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.7314\/APJCP.2015.16.13.5541","article-title":"Systematic review of single large and\/or multinodular hepatocellular carcinoma: surgical resection improves survival","volume":"16","author":"Yang","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"10","key":"10.1016\/j.bbacli.2016.10.001_bb0065","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/lt.22362","article-title":"Can positron emission tomography with the dual tracers [11C]acetate and [18F]fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma?","volume":"17","author":"Cheung","year":"2011","journal-title":"Liver Transpl."},{"issue":"2","key":"10.1016\/j.bbacli.2016.10.001_bb0070","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2967\/jnumed.112.107516","article-title":"11C-acetate and 18F-FDG PET\/CT for clinical staging and selection of patients with hepatocellular carcinoma for liver transplantation on the basis of Milan criteria: surgeon's perspective","volume":"54","author":"Cheung","year":"2013","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.bbacli.2016.10.001_bb0075","article-title":"Should hepatic resection be recommended to patients with hepatocellular carcinoma and portal vein invasion?","author":"Wang","year":"2016","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbacli.2016.10.001_bb0080","doi-asserted-by":"crossref","DOI":"10.1111\/liv.13208","article-title":"Is radioembolization or sorafenib the best option for patients with hepatocellular carcinoma and portal vein invasion?","author":"Liao","year":"2016","journal-title":"Liver Int."},{"issue":"1","key":"10.1016\/j.bbacli.2016.10.001_bb0085","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000000381","article-title":"A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL\/AASLD recommendations? An observational study of the HCC East-West Study Group","volume":"262","author":"Bruix","year":"2015","journal-title":"Ann. Surg."},{"issue":"1","key":"10.1016\/j.bbacli.2016.10.001_bb0090","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1097\/SLA.0000000000000383","article-title":"Reply to letter: \u201cdissecting EASL\/AASLD recommendations with a more careful knife: a comment on \u2018surgical misinterpretation\u2019 of the BCLC staging system\u201d: real misinterpretation or lack of clarity within the BCLC?","volume":"262","author":"Torzilli","year":"2015","journal-title":"Ann. Surg."},{"issue":"1","key":"10.1016\/j.bbacli.2016.10.001_bb0095","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1097\/SLA.0000000000000382","volume":"262","author":"Torzilli","year":"2015","journal-title":"Ann. Surg."},{"key":"10.1016\/j.bbacli.2016.10.001_bb0100","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000001922","article-title":"We're still in an update process of the BCLC system","author":"Zhong","year":"2016","journal-title":"Ann. Surg."},{"issue":"2","key":"10.1016\/j.bbacli.2016.10.001_bb0105","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/hep.27745","article-title":"The role of hepatic resection in the treatment of hepatocellular cancer","volume":"62","author":"Roayaie","year":"2015","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.bbacli.2016.10.001_bb0110","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/hep.27980","article-title":"Hepatic surgeons are like the child who rescued dying fishes","volume":"63","author":"Yang","year":"2016","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.bbacli.2016.10.001_bb0115","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/hep.27700","article-title":"Portal hypertension should not be a contraindication of hepatic resection to treat hepatocellular carcinoma with compensated cirrhosis","volume":"62","author":"Zhong","year":"2015","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.bbacli.2016.10.001_bb0120","doi-asserted-by":"crossref","DOI":"10.1038\/nrclinonc.2014.122-c3","article-title":"Intermediate-stage HCC\u2014upfront resection can be feasible","volume":"12","author":"Zhong","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bbacli.2016.10.001_bb0125","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/nrclinonc.2014.122-c1","article-title":"Heterogeneity of intermediate-stage HCC necessitates personalized management including surgery","volume":"12","author":"Gao","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bbacli.2016.10.001_bb0130","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/nrclinonc.2014.122-c2","article-title":"Reply: heterogeneity of intermediate-stage HCC necessitates personalized management including surgery","volume":"12","author":"Forner","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"27","key":"10.1016\/j.bbacli.2016.10.001_bb0135","doi-asserted-by":"crossref","first-page":"8256","DOI":"10.3748\/wjg.v21.i27.8256","article-title":"Grey zone in the Barcelona Clinic Liver Cancer Classification for hepatocellular carcinoma: surgeons' perspective","volume":"21","author":"Yang","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"38","key":"10.1016\/j.bbacli.2016.10.001_bb0140","first-page":"3115","article-title":"Hepatic resection for hepatocellular carcinoma involving a single large tumor, multiple tumors or macrovascular invasion","volume":"95","author":"Li","year":"2015","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"3","key":"10.1016\/j.bbacli.2016.10.001_bb0145","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/hep.27703","article-title":"Should surgery be carried out in patients with hepatocellular carcinoma with portal hypertension?","volume":"62","author":"Yang","year":"2015","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.bbacli.2016.10.001_bb0150","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.bbacli.2016.10.001_bb0155","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002722","article-title":"Preoperative ratio of Neutrophils to lymphocytes predicts postresection survival in selected patients with early or intermediate stage hepatocellular carcinoma","volume":"95","author":"Lu","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.bbacli.2016.10.001_bb0160","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.jhep.2012.11.009","article-title":"Comparison of resection and ablation for hepatocellular carcinoma: a cohort study based on a Japanese nationwide survey","volume":"58","author":"Hasegawa","year":"2013","journal-title":"J. Hepatol."},{"issue":"12","key":"10.1016\/j.bbacli.2016.10.001_bb0165","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1002\/bjs.8915","article-title":"Systematic review of outcomes of liver resection for early hepatocellular carcinoma within the Milan criteria","volume":"99","author":"Lim","year":"2012","journal-title":"Br. J. Surg."},{"issue":"7","key":"10.1016\/j.bbacli.2016.10.001_bb0170","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.ejca.2008.02.018","article-title":"The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma - survival analysis of 3892 patients","volume":"44","author":"Wang","year":"2008","journal-title":"Eur. J. Cancer"},{"issue":"6","key":"10.1016\/j.bbacli.2016.10.001_bb0175","first-page":"403","article-title":"Tumor stage and primary treatment selection among patients with hepatocellular carcinoma from 2003 to 2013","volume":"7","author":"Zhong","year":"2015","journal-title":"Chin. J. Oncol Prev. Treat."},{"issue":"11","key":"10.1016\/j.bbacli.2016.10.001_bb0180","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S1470-2045(09)70241-4","article-title":"Management of hepatocellular carcinoma in Asia: CONSENSUS statement from the Asian Oncology Summit 2009","volume":"10","author":"Poon","year":"2009","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.bbacli.2016.10.001_bb0185","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000449336","article-title":"Surgery for intermediate and advanced hepatocellular carcinoma: a consensus report from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014)","volume":"5","author":"Ho","year":"2016","journal-title":"Liver Cancer"},{"issue":"3","key":"10.1016\/j.bbacli.2016.10.001_bb0190","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-2007-1007122","article-title":"Prognosis of hepatocellular carcinoma: the BCLC staging classification","volume":"19","author":"Llovet","year":"1999","journal-title":"Semin. Liver Dis."},{"issue":"3","key":"10.1016\/j.bbacli.2016.10.001_bb0195","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/hep.510280322","volume":"28","year":"1998","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.bbacli.2016.10.001_bb0200","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0168-8278(99)80173-1","article-title":"A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire","volume":"31","author":"Chevret","year":"1999","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.bbacli.2016.10.001_bb0205","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1002\/cncr.10384","article-title":"Construction of the Chinese University Prognostic Index for hepatocellular carcinoma and comparison with the TNM staging system, the Okuda staging system, and the Cancer of the Liver Italian Program staging system: a study based on 926 patients","volume":"94","author":"Leung","year":"2002","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.bbacli.2016.10.001_bb0210","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s005350300038","article-title":"Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging score (JIS score)","volume":"38","author":"Kudo","year":"2003","journal-title":"J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.bbacli.2016.10.001_bb0215","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1053\/j.gastro.2014.02.032","article-title":"Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma","volume":"146","author":"Yau","year":"2014","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.bbacli.2016.10.001_bb0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002006","article-title":"Development and validation of a new prognostic system for patients with hepatocellular carcinoma","volume":"13","author":"Farinati","year":"2016","journal-title":"PLoS Med."},{"key":"10.1016\/j.bbacli.2016.10.001_bb0225","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejca.2016.04.023","article-title":"Proposal and validation of a new model to estimate survival for hepatocellular carcinoma patients","volume":"63","author":"Liu","year":"2016","journal-title":"Eur. J. Cancer"},{"issue":"6","key":"10.1016\/j.bbacli.2016.10.001_bb0230","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/liv.13045","article-title":"Assessment of the Hong Kong Liver Cancer staging system in Europe","volume":"36","author":"Kolly","year":"2016","journal-title":"Liver Int."},{"issue":"10","key":"10.1016\/j.bbacli.2016.10.001_bb0235","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/MEG.0000000000000418","article-title":"Validation of models in patients with hepatocellular carcinoma: comparison of Hong Kong Liver Cancer with Barcelona Clinic Liver Cancer staging system in a Chinese cohort","volume":"27","author":"Yan","year":"2015","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"41","key":"10.1016\/j.bbacli.2016.10.001_bb0240","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001772","article-title":"Hong Kong Liver Cancer staging system is associated with better performance for hepatocellular carcinoma: special emphasis on viral etiology","volume":"94","author":"Liu","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.bbacli.2016.10.001_bb0245","doi-asserted-by":"crossref","DOI":"10.1111\/liv.13107","article-title":"The recommended treatment algorithms of the BCLC and HKLC staging systems: does following these always improve survival rates for HCC patients?","author":"Kim","year":"2016","journal-title":"Liver Int."},{"issue":"5","key":"10.1016\/j.bbacli.2016.10.001_bb0250","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00432-010-0935-3","article-title":"A new staging system for resectable hepatocellular carcinoma: comparison with six existing staging systems in a large Chinese cohort","volume":"137","author":"Yang","year":"2011","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.bbacli.2016.10.001_bb0255","first-page":"348","article-title":"Heterogeneity of patients with intermediate (BCLC B) hepatocellular carcinoma: proposal for a subclassification to facilitate treatment decisions","volume":"32","author":"Bolondi","year":"2012","journal-title":"Semin. Liver Dis."},{"issue":"4","key":"10.1016\/j.bbacli.2016.10.001_bb0260","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1053\/j.gastro.2015.12.041","article-title":"Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma","volume":"150","author":"Bruix","year":"2016","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.bbacli.2016.10.001_bb0265","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nrclinonc.2014.122","article-title":"Treatment of intermediate-stage hepatocellular carcinoma","volume":"11","author":"Forner","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.bbacli.2016.10.001_bb0270","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/gutjnl-2013-306627","article-title":"Hepatocellular carcinoma: clinical frontiers and perspectives","volume":"63","author":"Bruix","year":"2014","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.bbacli.2016.10.001_bb0275","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2217\/hep.15.18","article-title":"Surgical treatment of hepatocellular carcinoma: should resection be performed according to Barcelona Clinic Liver Cancer classification?","volume":"2","author":"Fuster","year":"2015","journal-title":"Hepat. Oncol."},{"issue":"7","key":"10.1016\/j.bbacli.2016.10.001_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068193","article-title":"Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization","volume":"8","author":"Zhong","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bbacli.2016.10.001_bb0285","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s00268-012-1840-5","article-title":"Long-term outcome after liver resection for hepatocellular carcinoma larger than 10cm","volume":"37","author":"Allemann","year":"2013","journal-title":"World J. Surg."},{"issue":"4","key":"10.1016\/j.bbacli.2016.10.001_bb0290","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/jso.23226","article-title":"Impact of hepatectomy for huge solitary hepatocellular carcinoma","volume":"107","author":"Ariizumi","year":"2013","journal-title":"J. Surg. Oncol."},{"issue":"5","key":"10.1016\/j.bbacli.2016.10.001_bb0295","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.surg.2012.03.024","article-title":"Hepatic resection can provide long-term survival of patients with non-early-stage hepatocellular carcinoma: extending the indication for resection?","volume":"152","author":"Chang","year":"2012","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.bbacli.2016.10.001_bb0300","first-page":"178","article-title":"Surgical resection of centrally located large hepatocellular carcinoma","volume":"35","author":"Cheng","year":"2012","journal-title":"Chang Gung Med. J."},{"issue":"6","key":"10.1016\/j.bbacli.2016.10.001_bb0305","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archsurg.143.6.538","article-title":"Treatment of stage IVA hepatocellular carcinoma: should we reappraise the role of surgery?","volume":"143","author":"Chirica","year":"2008","journal-title":"Arch. Surg."},{"issue":"4","key":"10.1016\/j.bbacli.2016.10.001_bb0310","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00268-006-0359-z","article-title":"Outcomes of hepatic resection for a single large hepatocellular carcinoma","volume":"31","author":"Cho","year":"2007","journal-title":"World J. Surg."},{"issue":"5","key":"10.1016\/j.bbacli.2016.10.001_bb0315","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.amjsurg.2008.09.019","article-title":"Outcome after curative resection for a huge (>or=10cm) hepatocellular carcinoma and prognostic significance of gross tumor classification","volume":"198","author":"Choi","year":"2009","journal-title":"Am. J. Surg."},{"issue":"4","key":"10.1016\/j.bbacli.2016.10.001_bb0320","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.suronc.2009.05.003","article-title":"Hepatic resection for hepatocellular carcinoma exceeding Milan criteria","volume":"19","author":"Delis","year":"2010","journal-title":"Surg. Oncol."},{"issue":"7","key":"10.1016\/j.bbacli.2016.10.001_bb0325","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s00268-012-1544-x","article-title":"Is there any benefit from expanding the criteria for the resection of hepatocellular carcinoma in cirrhotic liver? Experience from a developing country","volume":"36","author":"Galun","year":"2012","journal-title":"World J. Surg."},{"issue":"4","key":"10.1016\/j.bbacli.2016.10.001_bb0330","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1245\/s10434-008-0282-7","article-title":"Liver resection improves the survival of patients with multiple hepatocellular carcinomas","volume":"16","author":"Ho","year":"2009","journal-title":"Ann. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.bbacli.2016.10.001_bb0335","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1245\/s10434-011-2060-1","article-title":"Comparison of surgical resection and transarterial chemoembolization for hepatocellular carcinoma beyond the Milan criteria: a propensity score analysis","volume":"19","author":"Hsu","year":"2012","journal-title":"Ann. Surg. Oncol."},{"issue":"8","key":"10.1016\/j.bbacli.2016.10.001_bb0340","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/jso.23172","article-title":"Liver resection for complicated hepatocellular carcinoma: challenges but opportunity for long-term survivals","volume":"106","author":"Huang","year":"2012","journal-title":"J. Surg. Oncol."},{"issue":"9","key":"10.1016\/j.bbacli.2016.10.001_bb0345","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1872-034X.2007.00119.x","article-title":"Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan","volume":"37","author":"Ikai","year":"2007","journal-title":"Hepatol. Res."},{"issue":"3","key":"10.1016\/j.bbacli.2016.10.001_bb0350","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1002\/bjs.5622","article-title":"Outcome of patients with huge hepatocellular carcinoma after primary resection and treatment of recurrent lesions","volume":"94","author":"Lee","year":"2007","journal-title":"Br. J. Surg."},{"issue":"9","key":"10.1016\/j.bbacli.2016.10.001_bb0355","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1007\/s00268-010-0598-x","article-title":"Comparing hepatic resection and transarterial chemoembolization for Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma: change for treatment of choice?","volume":"34","author":"Lin","year":"2010","journal-title":"World J. Surg."},{"issue":"1","key":"10.1016\/j.bbacli.2016.10.001_bb0360","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1148\/radiol.10101072","article-title":"Hepatic resection versus transarterial lipiodol chemoembolization as the initial treatment for large, multiple, and resectable hepatocellular carcinomas: a prospective nonrandomized analysis","volume":"259","author":"Luo","year":"2011","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.bbacli.2016.10.001_bb0365","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1477-2574.2009.00044.x","article-title":"Prognostic determinants for survival after resection\/ablation of a large hepatocellular carcinoma","volume":"11","author":"Ng","year":"2009","journal-title":"HPB (Oxford)"},{"issue":"10","key":"10.1016\/j.bbacli.2016.10.001_bb0370","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1245\/s10434-007-9518-1","article-title":"Long term outcome and prognostic factors for large hepatocellular carcinoma (10cm or more) after surgical resection","volume":"14","author":"Pandey","year":"2007","journal-title":"Ann. Surg. Oncol."},{"issue":"11","key":"10.1016\/j.bbacli.2016.10.001_bb0375","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1177\/000313481007601116","article-title":"Does surgical resection have a role in the treatment of large or multinodular hepatocellular carcinoma?","volume":"76","author":"Ramacciato","year":"2010","journal-title":"Am. Surg."},{"issue":"7","key":"10.1016\/j.bbacli.2016.10.001_bb0380","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s11605-009-0903-x","article-title":"Is liver resection justified in advanced hepatocellular carcinoma? Results of an observational study in 464 patients","volume":"13","author":"Ruzzenente","year":"2009","journal-title":"J. Gastrointest. Surg."},{"issue":"2","key":"10.1016\/j.bbacli.2016.10.001_bb0385","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/jso.21461","article-title":"Factors associated with recurrence and survival following hepatectomy for large hepatocellular carcinoma: a multicenter analysis","volume":"101","author":"Schiffman","year":"2010","journal-title":"J. Surg. Oncol."},{"issue":"5","key":"10.1016\/j.bbacli.2016.10.001_bb0390","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s11605-007-0154-7","article-title":"Prognosis and results after resection of very large (>or=10cm) hepatocellular carcinoma","volume":"11","author":"Shah","year":"2007","journal-title":"J. Gastrointest. Surg."},{"issue":"4","key":"10.1016\/j.bbacli.2016.10.001_bb0395","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00423-007-0264-4","article-title":"Role of a hepatectomy for the treatment of large hepatocellular carcinomas measuring 10cm or larger in diameter","volume":"393","author":"Shimada","year":"2008","journal-title":"Langenbeck's Arch. Surg."},{"issue":"2","key":"10.1016\/j.bbacli.2016.10.001_bb0400","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jso.23246","article-title":"Resection of large hepatocellular carcinoma (>\/=10cm): a unique western perspective","volume":"107","author":"Shrager","year":"2013","journal-title":"J. Surg. Oncol."},{"issue":"4","key":"10.1016\/j.bbacli.2016.10.001_bb0405","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1007\/s00534-007-1317-3","article-title":"Adaptation of hepatectomy for huge hepatocellular carcinoma","volume":"15","author":"Taniai","year":"2008","journal-title":"J. Hepato-Biliary-Pancreat. Surg."},{"issue":"12","key":"10.1016\/j.bbacli.2016.10.001_bb0410","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.ejso.2012.07.112","article-title":"Tumor size of hepatocellular carcinoma in noncirrhotic liver: a controversial predictive factor for outcome after resection","volume":"38","author":"Truant","year":"2012","journal-title":"Eur. J. Surg. Oncol."},{"issue":"8","key":"10.1016\/j.bbacli.2016.10.001_bb0415","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0929-6646(08)60179-5","article-title":"Is hepatectomy beneficial in the treatment of multinodular hepatocellular carcinoma?","volume":"107","author":"Wang","year":"2008","journal-title":"J. Formos. Med. Assoc."},{"issue":"10","key":"10.1016\/j.bbacli.2016.10.001_bb0420","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1007\/s00268-010-0664-4","article-title":"Prognostic factors and outcome of 438 Chinese patients with hepatocellular carcinoma underwent partial hepatectomy in a single center","volume":"34","author":"Wang","year":"2010","journal-title":"World J. Surg."},{"issue":"3","key":"10.1016\/j.bbacli.2016.10.001_bb0425","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/jso.21931","article-title":"Outcomes of hepatic resection for huge hepatocellular carcinoma (>\/=10cm in diameter)","volume":"104","author":"Yamashita","year":"2011","journal-title":"J. Surg. Oncol."},{"issue":"1","key":"10.1016\/j.bbacli.2016.10.001_bb0430","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/SLA.0b013e3181904988","article-title":"Solitary large hepatocellular carcinoma: a specific subtype of hepatocellular carcinoma with good outcome after hepatic resection","volume":"249","author":"Yang","year":"2009","journal-title":"Ann. Surg."},{"issue":"4","key":"10.1016\/j.bbacli.2016.10.001_bb0435","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s00268-013-2365-2","article-title":"Tumor size does not independently affect long-term survival after curative resection of solitary hepatocellular carcinoma without macroscopic vascular invasion","volume":"38","author":"Zhang","year":"2014","journal-title":"World J. Surg."},{"issue":"2","key":"10.1016\/j.bbacli.2016.10.001_bb0440","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/SLA.0000000000000236","article-title":"Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma","volume":"260","author":"Zhong","year":"2014","journal-title":"Ann. Surg."},{"issue":"6","key":"10.1016\/j.bbacli.2016.10.001_bb0445","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ejso.2011.03.137","article-title":"Prognostic factors of solitary large hepatocellular carcinoma: the importance of differentiation grade","volume":"37","author":"Zhou","year":"2011","journal-title":"Eur. J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.bbacli.2016.10.001_bb0450","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000000396","article-title":"Hepatic resection as a safe and effective treatment for hepatocellular carcinoma involving a single large tumor, multiple tumors, or macrovascular invasion","volume":"94","author":"Zhong","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"10.1016\/j.bbacli.2016.10.001_bb0455","doi-asserted-by":"crossref","first-page":"8355","DOI":"10.1007\/s13277-014-2571-z","article-title":"Hepatic resection associated with good survival for selected patients with multinodular hepatocellular carcinoma","volume":"35","author":"Zhong","year":"2014","journal-title":"Tumour Biol."},{"issue":"21","key":"10.1016\/j.bbacli.2016.10.001_bb0460","doi-asserted-by":"crossref","first-page":"18715","DOI":"10.18632\/oncotarget.4134","article-title":"Hepatic resection versus transarterial chemoembolization for the initial treatment of hepatocellular carcinoma: a systematic review and meta-analysis","volume":"6","author":"Qi","year":"2015","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.bbacli.2016.10.001_bb0465","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s11605-015-2811-6","article-title":"Hepatic resection improved the long-term survival of patients with BCLC stage B hepatocellular carcinoma in Asia: a systematic review and meta-analysis","volume":"19","author":"Liu","year":"2015","journal-title":"J. Gastrointest. Surg."},{"issue":"1","key":"10.1016\/j.bbacli.2016.10.001_bb0470","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jhep.2014.03.012","article-title":"Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan criteria: a RCT","volume":"61","author":"Yin","year":"2014","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.bbacli.2016.10.001_bb0475","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/MEG.0000000000000527","article-title":"Hepatocellular carcinoma in cirrhotic versus noncirrhotic livers: results from a large cohort in the Netherlands","volume":"28","author":"van Meer","year":"2016","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.bbacli.2016.10.001_bb0480","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s00534-009-0232-1","article-title":"Surgical technique: new advancements for expanding indications and safety: the Western experience","volume":"17","author":"Torzilli","year":"2010","journal-title":"J Hepatobiliary Pancreat. Sci."},{"issue":"2","key":"10.1016\/j.bbacli.2016.10.001_bb0485","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1007\/s13277-015-4091-x","article-title":"Propensity score-based comparison of hepatic resection and transarterial chemoembolization for patients with advanced hepatocellular carcinoma","volume":"37","author":"Yuan","year":"2016","journal-title":"Tumour Biol."},{"issue":"19","key":"10.1016\/j.bbacli.2016.10.001_bb0490","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1002\/cncr.26561","article-title":"Hepatic resection versus transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with portal vein tumor thrombus","volume":"118","author":"Peng","year":"2012","journal-title":"Cancer"},{"issue":"45","key":"10.1016\/j.bbacli.2016.10.001_bb0495","doi-asserted-by":"crossref","first-page":"17141","DOI":"10.3748\/wjg.v20.i45.17141","article-title":"Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus","volume":"20","author":"Ye","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.bbacli.2016.10.001_bb0500","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1007\/s00432-012-1188-0","article-title":"Surgical resection for advanced hepatocellular carcinoma according to Barcelona Clinic Liver Cancer (BCLC) staging","volume":"138","author":"Yang","year":"2012","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.bbacli.2016.10.001_bb0505","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.dld.2016.04.016","article-title":"Comparison of the prognostic influence of emergency hepatectomy and staged hepatectomy in patients with ruptured hepatocellular carcinoma","volume":"48","author":"Ou","year":"2016","journal-title":"Dig. Liver Dis."},{"issue":"6","key":"10.1016\/j.bbacli.2016.10.001_bb0510","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1245\/s10434-010-1484-3","article-title":"Continuous occlusion of hepatic artery proper for prevention of blood loss in partial hepatectomy for ruptured hepatocellular carcinoma: a case-matched comparative study","volume":"18","author":"Xia","year":"2011","journal-title":"Ann. Surg. Oncol."},{"issue":"8","key":"10.1016\/j.bbacli.2016.10.001_bb0515","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/bjs.9167","article-title":"Partial hepatectomy for ruptured hepatocellular carcinoma","volume":"100","author":"Yang","year":"2013","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.bbacli.2016.10.001_bb0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2016.05.044","article-title":"Survival benefit of liver resection for hepatocellular carcinoma associated with portal vein invasion","author":"Kokudo","year":"2016","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.bbacli.2016.10.001_bb0525","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154986","article-title":"radioembolization is a safe and effective treatment for hepatocellular carcinoma with portal vein thrombosis: a propensity score analysis","volume":"11","author":"Cho","year":"2016","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.bbacli.2016.10.001_bb0530","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/liv.13098","article-title":"A comparison of survival in patients with hepatocellular carcinoma and portal vein invasion treated by radioembolization or sorafenib","volume":"36","author":"de la Torre","year":"2016","journal-title":"Liver Int."},{"issue":"6","key":"10.1016\/j.bbacli.2016.10.001_bb0535","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/bjs.8753","article-title":"Hepatic venous pressure gradient in the assessment of portal hypertension before liver resection in patients with cirrhosis","volume":"99","author":"Boleslawski","year":"2012","journal-title":"Br. J. Surg."},{"issue":"1","key":"10.1016\/j.bbacli.2016.10.001_bb0540","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jhep.2015.08.025","article-title":"Hepatic venous pressure gradient in the preoperative assessment of patients with resectable hepatocellular carcinoma","volume":"64","author":"Cucchetti","year":"2016","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.bbacli.2016.10.001_bb0545","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1148\/radiol.14141210","article-title":"Prospective comparison of spleen and liver stiffness by using shear-wave and transient elastography for detection of portal hypertension in cirrhosis","volume":"275","author":"Elkrief","year":"2015","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.bbacli.2016.10.001_bb0550","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jhep.2016.01.041","article-title":"Hepatic venous pressure gradient for preoperative assessment of patients with resectable hepatocellular carcinoma: a comment for moving forward","volume":"65","author":"Zhong","year":"2016","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.bbacli.2016.10.001_bb0555","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/hep.27431","article-title":"Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: a systematic review and meta-analysis","volume":"61","author":"Berzigotti","year":"2015","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.bbacli.2016.10.001_bb0560","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1478-3231.2010.02436.x","article-title":"Predictive factors for long-term survival in patients with clinically significant portal hypertension following resection of hepatocellular carcinoma","volume":"31","author":"Choi","year":"2011","journal-title":"Liver Int."},{"issue":"6","key":"10.1016\/j.bbacli.2016.10.001_bb0565","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/SLA.0b013e3181b977a5","article-title":"Is portal hypertension a contraindication to hepatic resection?","volume":"250","author":"Cucchetti","year":"2009","journal-title":"Ann. Surg."},{"issue":"10","key":"10.1016\/j.bbacli.2016.10.001_bb0570","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/liv.12199","article-title":"Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients","volume":"33","author":"Giannini","year":"2013","journal-title":"Liver Int."},{"issue":"9","key":"10.1016\/j.bbacli.2016.10.001_bb0575","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/bjs.8861","article-title":"Intraoperative portal venous pressure and long-term outcome after curative resection for hepatocellular carcinoma","volume":"99","author":"Hidaka","year":"2012","journal-title":"Br. J. Surg."},{"issue":"6","key":"10.1016\/j.bbacli.2016.10.001_bb0580","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1245\/s10434-008-9880-7","article-title":"Short- and long-term outcomes after hepatic resection for hepatocellular carcinoma with concomitant esophageal varices in patients with cirrhosis","volume":"15","author":"Kawano","year":"2008","journal-title":"Ann. Surg. Oncol."},{"issue":"46","key":"10.1016\/j.bbacli.2016.10.001_bb0585","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.3748\/wjg.v17.i46.5083","article-title":"Hepatocellular carcinoma in cirrhotic patients with portal hypertension: is liver resection always contraindicated?","volume":"17","author":"Ruzzenente","year":"2011","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.bbacli.2016.10.001_bb0590","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1477-2574.2012.00594.x","article-title":"Hepatic resection for hepatocellular carcinoma in patients with Child-Pugh's A cirrhosis: is clinical evidence of portal hypertension a contraindication?","volume":"15","author":"Santambrogio","year":"2013","journal-title":"HPB (Oxford)"},{"issue":"9","key":"10.1016\/j.bbacli.2016.10.001_bb0595","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108755","article-title":"Hepatic resection is safe and effective for patients with hepatocellular carcinoma and portal hypertension","volume":"9","author":"Zhong","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bbacli.2016.10.001_bb0600","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1136\/gutjnl-2014-308139","article-title":"Liver resection for patients with hepatocellular carcinoma and macrovascular invasion, multiple tumours, or portal hypertension","volume":"64","author":"Zhong","year":"2015","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.bbacli.2016.10.001_bb0605","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s00268-016-3465-6","article-title":"Comparison of the outcomes of patients with hepatocellular carcinoma and portal hypertension after liver resection versus radiofrequency ablation","volume":"40","author":"Harada","year":"2016","journal-title":"World J. Surg."},{"issue":"6","key":"10.1016\/j.bbacli.2016.10.001_bb0610","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1007\/s11605-016-3132-0","article-title":"Predicting individual survival after hepatectomy for hepatocellular carcinoma: a novel nomogram from the \u201cHCC East & West Study Group\u201d","volume":"20","author":"Torzilli","year":"2016","journal-title":"J. Gastrointest. Surg."},{"issue":"6","key":"10.1016\/j.bbacli.2016.10.001_bb0615","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/bjs.10095","article-title":"Albumin-bilirubin versus Child-Pugh score as a predictor of outcome after liver resection for hepatocellular carcinoma","volume":"103","author":"Wang","year":"2016","journal-title":"Br. J. Surg."},{"issue":"10","key":"10.1016\/j.bbacli.2016.10.001_bb0620","doi-asserted-by":"crossref","first-page":"9459","DOI":"10.1007\/s13277-014-2443-6","article-title":"Adjuvant and chemopreventive therapies for resectable hepatocellular carcinoma: a literature review","volume":"35","author":"Zhong","year":"2014","journal-title":"Tumour Biol."},{"issue":"6","key":"10.1016\/j.bbacli.2016.10.001_bb0625","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3109\/00365521.2014.905626","article-title":"Postoperative therapy options for hepatocellular carcinoma","volume":"49","author":"Zhong","year":"2014","journal-title":"Scand. J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.bbacli.2016.10.001_bb0630","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jss.2014.03.048","article-title":"Combined resection with radiofrequency ablation for bilobar hepatocellular carcinoma: a single-center experience","volume":"191","author":"Zhang","year":"2014","journal-title":"J. Surg. Res."}],"container-title":["BBA Clinical"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214647416300411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214647416300411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,10]],"date-time":"2022-07-10T12:44:53Z","timestamp":1657457093000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214647416300411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":126,"alternative-id":["S2214647416300411"],"URL":"https:\/\/doi.org\/10.1016\/j.bbacli.2016.10.001","relation":{},"ISSN":["2214-6474"],"issn-type":[{"value":"2214-6474","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Controversies and evidence of hepatic resection for hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"BBA Clinical","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbacli.2016.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}